Skip to main content
. 2012 Dec;24(4):291–298. doi: 10.3978/j.issn.1000-9604.2012.08.04

Table 2. Best overall response rates in two groups.

Tumor response Total (n=75) Group A (n=41) Group B (n=34)
Number of evaluable patients 71 40 31
   Confirmed CR 1 1 0
   Confirmed PR 22 15 7
   SD 38 20 18
   PD 10 4 6
Overall response rate (%) 32.4 40.0 22.6
mOS (months) 12.0 7.3
mPFS (months) 5.7 5.0

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; mOS, median overall survival; mPFS, median progression-free survival